UK Stock Market News: Cerillion, Greencoat, Arkle

Sep 14, 2026
uk-stock-market-news:-cerillion,-greencoat,-arkle

Three key news stories unfolding as the UK stock market opens. Check out our companies reporting diary for upcoming results from FTSE 350 and selected international stocks.

1. Cerillion to miss FY revenue and margin targets

AIM-listed CRM provider Cerillion LON:CER issued a full year trading update this morning. Despite a significant weighting in activity for the second half of the year, management note that the out turn will still be behind consensus forecasts. Revenues had been expected to come in around the £52m mark but that’s now set to be in the £46m-£48m range, with EBITDA margins also slightly lower than had previously been eyed. Delays and deferrals to customer orders are seen as being a key driver here.

2. Greencoat reverses first half losses, capital return programme underway

Greencoat Renewables [LON:GRP] issued interim results today, headlining with a EUR12m profit against a EUR68m loss for the comparative. That came despite energy generation being slightly below target and the share buyback programme announced in March is progressing well, with just over half of the EUR50m having been realised so far. There’s little about the outlook here but the stock is trading at around a 25% discount to NAV.

3. Positive Uranium find news from Arkle, assay results awaited

Energy metals explorer Arkle LON:ARK announced this morning that it had found an extensive uranium system as part of a project in Namibia. There’s a lot of detail in the regulatory filing but the key will be the return of assay results, the first of which are expected over the next couple of weeks. Actual uranium grades are not yet known.

In case you missed it

We start with the market outlook, as central banks prepare for what could be the biggest week of the year so far. With oil having surged above $100 a barrel and inflation still proving sticky, there are plenty of moving parts for investors to weigh up as the next round of interest-rate decisions approaches.

For our Plus+ members, our latest share tip focuses on a small-cap healthcare platform entering its next phase, with accelerating revenue and recurring income becoming an increasingly important part of the business.

We also take a look at GPT-6 Astra and what its launch could mean for investors. The latest generation of AI models is prompting a different question for the market: not simply how capable these systems can become, but how expensive the infrastructure and support required to run them will be.

Elsewhere, the VanEck Agribusiness ETF has launched on the London Stock Exchange, offering investors a way to gain exposure to the global agricultural supply chain, while Goldgroup is adding to its exploration story with results from its San Francisco project.

Look out for updates today from Big Technologies, Greencoat Renewables, HgCapital Trust, MP Evans and RTW Biotech Opportunities.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Leave a comment